Pretomanid in the Treatment of Patients with Tuberculosis in the United States.

Goswami, Neela D; Ashkin, David; Haley, Connie A

Goswami, Neela D; Ashkin, David; Haley, Connie A.

Goswami ND; Centers for Disease Control and Prevention, Atlanta, GA nef7@cdc.gov.
Ashkin D; University of Florida, Gainesville, FL.
Haley CA; University of Florida, Gainesville, FL.

N Engl J Med ; 387(9): 850-852, 2022 09 01.

Article en En | MEDLINE | ID: mdl-36053513

Asunto(s)

Antituberculosos; Mycobacterium tuberculosis; Nitroimidazoles; Tuberculosis; Antituberculosos/uso terapéutico; Humanos; Nitroimidazoles/efectos adversos; Nitroimidazoles/uso terapéutico; Tuberculosis/tratamiento farmacológico; Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis / Nitroimidazoles / Antituberculosos Límite: Humans País como asunto: America do norte Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google